DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Reactor production of Thorium-229

Journal Article · · Applied Radiation and Isotopes

Limited availability of 229Th for clinical applications of 213Bi necessitates investigation of alternative production routes. In reactor production, 229Th is produced from neutron transmutation of 226Ra, 228Ra, 227Ac and 228Th. Here, we evaluate irradiations of 226Ra, 228Ra, and 227Ac targets at the ORNL High Flux Isotope Reactor.

Research Organization:
Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
Sponsoring Organization:
USDOE Office of Nuclear Energy (NE)
Grant/Contract Number:
AC05-00OR22725
OSTI ID:
1253240
Journal Information:
Applied Radiation and Isotopes, Journal Name: Applied Radiation and Isotopes Journal Issue: C Vol. 114; ISSN 0969-8043
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English

References (18)

An overview of targeted alpha therapy journal December 2011
Generator-produced alpha-emitters journal April 1998
Numerical evaluation of the production of radionuclides in a nuclear reactor (Part II) journal April 1998
Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications journal September 2008
Cyclotron production of Ac-225 for targeted alpha therapy11Dedicated to Prof. Dr. Franz Baumgärtner on the occasion of his 75th birthday. journal March 2005
Production of actinium-225 for alpha particle mediated radioimmunotherapy journal May 2005
225Ac and 223Ra production via 800MeV proton irradiation of natural thorium targets journal November 2012
Proton-induced cross sections relevant to production of 225Ac and 223Ra in natural thorium targets below 200MeV journal November 2012
Production of Ac-225 from Th-229 for Targeted α Therapy journal October 2005
Thorium-229 for Medical Applications book November 2003
Reactor Production of Thorium-229 conference January 2005
Measurement of cross sections for the [sup 232]Th(P,4n)[sup 229]Pa reaction at low proton energies
  • Jost, C. U.; Griswold, J. R.; Bruffey, S. H.
  • APPLICATION OF ACCELERATORS IN RESEARCH AND INDUSTRY: Twenty-Second International Conference, AIP Conference Proceedings https://doi.org/10.1063/1.4802383
conference January 2013
New Treatment Option: 223Ra Chloride, the First Approved Unsealed α-Emitting Radiopharmaceutical journal January 2013
Decay of 37.5-min Th 236 and 9.1-min Pa 236 journal March 1984
Decay of 7.3-min Th 235 and 24.6-min Pa 235 journal June 1986
Production of 225Ac and 223Ra by irradiation of Th with accelerated protons journal February 2011
Yields of activation products in 226Ra irradiation in the high-flux SM reactor journal July 2012
Neutron dosimetry of the HFIR hydraulic facility report February 1995

Cited By (1)

Development of 225 Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences journal October 2018